🇺🇸 FDA
Patent

US 10442852

Methods and compositions for treatment of symptoms associated with intracranial hemorrhage

granted A61KA61K38/00A61P

Quick answer

US patent 10442852 (Methods and compositions for treatment of symptoms associated with intracranial hemorrhage) held by The Board of Regents of the University of Texas System expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P9/00